Information for "Pembrolizumab"
Jump to navigation
Jump to search
Basic information
| Display title | Pembrolizumab |
| Default sort key | Pembrolizumab |
| Page length (in bytes) | 28,098 |
| Namespace ID | 0 |
| Page ID | 277074 |
| Page content language | en - English |
| Page content model | wikitext |
| Indexing by robots | Allowed |
| Number of redirects to this page | 0 |
| Counted as a content page | Yes |
| Number of subpages of this page | 0 (0 redirects; 0 non-redirects) |
Page protection
| Edit | Allow all users (infinite) |
| Move | Allow all users (infinite) |
Edit history
| Page creator | Aparna Vuppala (talk | contribs) |
| Date of page creation | 13:41, 17 February 2015 |
| Latest editor | Badgettrg (talk | contribs) |
| Date of latest edit | 03:24, 6 February 2019 |
| Total number of edits | 18 |
| Total number of distinct authors | 3 |
| Recent number of edits (within past 30 days) | 0 |
| Recent number of distinct authors | 0 |
Page properties
| Magic words (2) |
|
| Transcluded templates (12) | Templates used on this page:
|